Long term use of oral contraceptives comprising synthetic estrogens induces an excessive breast cancer risk in BRCA mutation carrier women: a meta-analysis
Background: The relationship between oral contraceptive (OC) use and breast cancer risk is highly debated. Recent publications support a slight increase in overall breast cancer risk among OC user women, in particular among the current users. Women with inherited BRCA1 (Breast cancer type 1) or BRCA...
Saved in:
Main Authors: | Hongling Peng (Author), Xiaorong Qi (Author), Qiao Wang (Author) |
---|---|
Format: | Book |
Published: |
IMR Press,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DNA stabilization by the upregulation of estrogen signaling in BRCA gene mutation carriers
by: Suba Z
Published: (2015) -
Prophylactic adnexectomy in BRCA1 and BRCA2 gene mutation carriers (а review of literature)
by: T. A. Shendrikova, et al.
Published: (2014) -
Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriers
by: Alan D McCrorie, et al.
Published: (2020) -
Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers
by: Renata Faermann, et al.
Published: (2022) -
Fertility preservation in BRCA mutation carriers-efficacy and safety issues: a review
by: Xiaofu Zhang, et al.
Published: (2020)